|
The United States Versus Canada: Reimportation of Pharmaceuticals
The medical field, specifically the healthcare sector, has become an integral part of the life of American citizens. The price of prescription drugs has especially become no laughing matter in the United States. The cost of medications affect everyone, from newly married college graduates to America’s seniors. Now, individuals are looking to shop outside of the United States for their prescription drug needs. Take Canada, for example. Not only are people looking for these opportunities on their own, but some experts even recommend looking to other companies, such as Canadian drug companies, to find cheaper prescription drugs. Why are some experts in support of reimportation of drugs and why are others so opposed?
What Exactly Is Pharmaceutical Reimportation?
One of the biggest problems in the United States today is the high price of prescription drugs. The financial stress for Americans, especially those on a tight budget, has been i raised by the high cost of medicines often needed for survival. Reimportation refers to prescription drugs that are made in the United States, then sold to Canada, then purchased again by United States citizens. Why do this? Drugs purchased from Canada that are made by companies in the United States are cheaper when purchased through Canada than directly from the U.S. market.
The Upside To Reimportation
The most obvious upside to the reimportation of pharmaceuticals is the price savings for many common prescription drugs. These cost savings help seniors pay for their prescription drugs and help ensure that they are receiving the medication that they need for survival.
The Downside To Reimportation
Still, there are several downsides to reimportation. The biggest concern with the reimportation of pharmaceuticals is safety. The practice of reimportation creates yet one more step in the transportation and handling of drugs, putting more questionable distance between the drug’s origin and the ultimate patient. Experts warn that there exists the potential for drugs to be tampered with or otherwise contaminated. Also, the potential lack of purity poses problems that could lead to drugs losing their FDA approval status.
In conclusion, the reimportation of pharmaceuticals is a topic of much debate, especially in the world of politics. The main concern should not be the price of the drugs but instead the benefits and health of the patients.
contact@bigpharmadeals.com |